Vietnam Ophthalmology Society logoVIETNAMOPHTHALMOLOGY SOCIETY

AI for glaucoma and diabetic-retinopathy screening

News & EventsSource: Vietnam Ophthalmology Society
AI can support the analysis of retinal images and risk triage, helping to extend screening capacity at the point of care.
Contents

Artificial intelligence (AI) and deep learning in ophthalmology are creating additional tools to support screening for glaucoma and diabetic retinopathy — conditions that can cause irreversible visual damage when detected late.

Supporting diabetic-retinopathy screening

AI systems can analyse retinal photographs for signs such as microaneurysms, haemorrhages, hard exudates and retinal neovascularisation. Risk classification can help clinicians at primary-care level decide whether to monitor a patient or refer them to vitreoretinal care.

Analysing glaucoma risk

For glaucoma, AI can assist with analysis of the cup-to-disc ratio and retinal nerve-fibre layer in fundus images or OCT data. These tools do not replace eye examination, intraocular-pressure measurement, visual-field assessment or the clinical judgement of an ophthalmologist.

Value for communities

When deployed with appropriate safeguards, AI can increase screening capacity where specialist access is limited, shorten triage time and support chronic-disease management. Its use requires quality assurance, data protection and clear referral pathways.

Share article

View all news
Scientific sessions at VOS 2026

News & Events

Scientific sessions at VOS 2026

On 13 and 14 November 2026, several sessions ran in parallel at the Ariyana International Convention Centre in Da Nang. This article brings together the scientific sessions at VOS 2026 and ICOISG 12.